Can simple blood tests and ECGs predict sudden cardiac arrest?
NCT ID NCT01114269
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows over 5,700 people with coronary artery disease and mild heart damage to see if blood tests and ECGs can better predict who is at risk for sudden cardiac death. The goal is to find inexpensive markers that could help doctors decide who needs a defibrillator. Participants are not given any new treatment—only monitored over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
5,764 people
The number who actually took part.
- Started
-
Jul 2007
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction. 2. LVEF \>35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled. 3. If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF \>35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present. 4. Patients aged 18 years or above 1. CAD will be defined as evidence of one of the following two (2) criteria: * Significant stenosis of a major epicardial vessel (\>50% proximal or 70% distal) by coronary angiography * Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery) 2. MI can be documented in the following ways: * From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers \> 99th percentile of lab (e.g., CPK elevation or Troponin at least \> two times the upper limit of normal) together with myocardial ischemia with at least one of the following: * Symptoms of Ischemia * ECG changes indicative of new ischemia (new ST-T changes or new LBBB) * Development of pathological Q waves * Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality * If no report from the MI hospitalization is available, prior MI can be met by either of the following: * Development of pathological Q waves * Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause Exclusion Criteria: 1. History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion). 2. Unexplained syncope 3. Current or planned implantable cardiac defibrillator (ICD) 4. Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival) 5. Metastatic cancer 6. Marked valvular heart disease requiring surgical intervention 7. Current or planned cardiac, renal or liver transplant 8. Current alcohol or drug abuse 9. Unwilling or unable to provide informed consent 10. LVEF \<35% with Class II-IV CHF or LVEF \<30% 11. Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abington Memorial Hospital
Abington, Pennsylvania, 19001, United States
-
Advanced Heartcare, LLC
Bridgewater, New Jersey, 08807, United States
-
Advocate Medical Group
Chicago, Illinois, 60643, United States
-
Advocate Medical Group - Heart and Vascular of IL
Chicago, Illinois, 60657, United States
-
Alaska Heart Institute
Anchorage, Alaska, 99508, United States
-
Albany Associates Cardiology
Albany, New York, 12205, United States
-
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
AnMed Health
Anderson, South Carolina, 29621, United States
-
Asheville Cardiology Associates
Asheville, North Carolina, 28801, United States
-
Baptist Health Lexington
Lexington, Kentucky, 40503, United States
-
Bay Area Cardiology Associates, P.A.
Brandon, Florida, 33511, United States
-
Baystate Cardiology
Springfield, Massachusetts, 01199, United States
-
Beaver Medical Group/Clinical Care Research
Banning, California, 92220, United States
-
Black Hills Cardiovascular Research
Rapid City, South Dakota, 57701, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Buffalo General Hospital/Kaleida Health
Buffalo, New York, 14203, United States
-
Cardiology Associates of Palm Beach - West Palm Beach
West Palm Beach, Florida, 33401, United States
-
Cardiovascular Associates Virginia Beach
Virginia Beach, Virginia, 23454, United States
-
Cardiovascular Consultants
Phoenix, Arizona, 85032, United States
-
Cardiovasular Research of Knoxville
Knoxville, Tennessee, 37917, United States
-
Carolina Cardiology Associates
Rock Hill, South Carolina, 29732, United States
-
Colorado Heart and Vascular
Denver, Colorado, 80204, United States
-
Columbia University Health Center
New York, New York, 10032, United States
-
Community Heart and Vascular
Anderson, Indiana, 46011, United States
-
Consultants in Cardiovascular Medicine
Melrose Park, Illinois, 60160, United States
-
Doylestown Cardiology Associates
Doylestown, Pennsylvania, 18901, United States
-
Eastern Carolina Cardiovascular
Elizabeth City, North Carolina, 27909, United States
-
Florida Hospital
Orlando, Florida, 32804, United States
-
Georgia Heart Specialist
Covington, Georgia, 30014, United States
-
Glacier View Cardiology
Kalispell, Montana, 59901, United States
-
Gotham Cardiovascular
New York, New York, 10001, United States
-
Hawthorn Medical Associates
North Dartmouth, Massachusetts, 02747, United States
-
Intermountain Medical Center
Murray, Utah, 84157, United States
-
Iowa Heart Center
West Des Moines, Iowa, 50266, United States
-
Jamaica Hospital Medical Center
Jamaica, New York, 11418, United States
-
Leonard J. Chabert Medical Center
Houma, Louisiana, 70363, United States
-
Maimonides Medical Center
Brooklyn, New York, 11219, United States
-
Maine Research Associates
Auburn, Maine, 04210, United States
-
Maine Research Associates - Lewiston
Lewiston, Maine, 04240, United States
-
McLaren Medical Center - Macomb
Mount Clemens, Michigan, 48043, United States
-
Memorial Health System
Colorado Springs, Colorado, 80909, United States
-
Memphis VA Medical Center
Memphis, Tennessee, 38104, United States
-
Mercy Medical Associates
Fairfield, Ohio, 45014, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
-
Michigan Heart
Ypsilanti, Michigan, 48197, United States
-
Mid-Valley Cardiology
Kingston, New York, 12401, United States
-
Minneapolis VA Medical Center
Minneapolis, Minnesota, 55417, United States
-
Mississauga Clinical Research Centre
Mississauga, Ontario, L5B 2P7, Canada
-
Mount Sinai Medical Center
Miami Beach, Florida, 33140, United States
-
NECCR Internal Medicine and Cardiology Associates, LLC
Fall River, Massachusetts, 02720, United States
-
New Mexico VA Healthcare Systems
Albuquerque, New Mexico, 87108, United States
-
Non-Invasive Cardiovascular PA
Houston, Texas, 77074, United States
-
North Ohio Research, Ltd.
Elyria, Ohio, 44035, United States
-
Northeast Georgia Heart Center, P.C.
Gainesville, Georgia, 30501, United States
-
Northeast Ohio Cardiovascular Specialists
Akron, Ohio, 44304, United States
-
Northstate Clinical Research
Lenoir, North Carolina, 28645, United States
-
Northwest Ohio Cardiology Consultants/The Toledo Hospital
Toledo, Ohio, 43615, United States
-
Oakwood Hospital & Medical Center
Dearborn, Michigan, 48124, United States
-
Oklahoma City VA Medical Center Veterans Research and Education Foundation
Oklahoma City, Oklahoma, 73104, United States
-
Oklahoma Foundation for Cardiovascular Research
Oklahoma City, Oklahoma, 73120, United States
-
Orlando Regional Medical Center
Orlando, Florida, 32806, United States
-
Palm Beach Gardens Research Center
Palm Beach Gardens, Florida, 33410, United States
-
Phoenix Heart, PLLC
Glendale, Arizona, 85306, United States
-
Pinehurst Medical Clinic, Inc.
Pinehurst, North Carolina, 28374, United States
-
Primary Care Cardiology Research
Ayer, Massachusetts, 01432, United States
-
Providence Health Center
Waco, Texas, 76712, United States
-
Reliable Clinical Research
Miami, Florida, 33135, United States
-
Sanford Cardiology
Sanford, North Carolina, 27330, United States
-
St. Elizabeth Medical Center - Hotvedt
Utica, New York, 13501, United States
-
St. Joseph Regional Medical Center
Paterson, New Jersey, 07503, United States
-
St. Luke's Bethlehem
Bethlehem, Pennsylvania, 18018, United States
-
St. Luke's Episcopal Hospital
Houston, Texas, 77030, United States
-
Stony Brook University Medical Center
Stony Brook, New York, 11794, United States
-
Tallahassee Research Institute, Inc.
Tallahassee, Florida, 32308, United States
-
The Cardiac Center of Creighton University
Omaha, Nebraska, 68131, United States
-
The University of Kansas
Kansas City, Kansas, 66160, United States
-
Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
Rio Piedras, 00924, Puerto Rico
-
University of Alberta
Edmonton, Alberta, T6G 2B7, Canada
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Florida - Gainsville
Gainesville, Florida, 32610, United States
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
-
University of Michigan Medical Center
Ann Arbor, Michigan, 48109, United States
-
University of Missouri Health Care
Columbia, Missouri, 65201, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
VA Medical Center - Charleston
Charleston, South Carolina, 29425, United States
-
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
-
Velella Research
Sarasota, Florida, 34233, United States
-
Wake Forest
Winston-Salem, North Carolina, 27157, United States
-
Winthrop-University Hospital
Mineola, New York, 11501, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heart stent patients go home in 6 hours?
- Can AI read heart scans to predict the next heart attack?
- Can a new drug cool the hidden inflammation that fuels heart disease?
- New CT scanner aims to cut unnecessary heart procedures
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time